Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure

Background: Growing evidence shows that impaired signaling of Insulin-like Growth Factor-1 (IGF-1) is associated with neurodegenerative disorders, such as Parkinson's disease (PD). However, there is still controversy regarding its proinflammatory or neuroprotective function. In an attempt to el...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazi Sherbaf, Farzaneh, Mohajer, Bahram, Ashraf-Ganjouei, Amir, Mojtahed Zadeh, Mahtab, Javinani, Ali, Sanjari Moghaddam, Hossein, Shirin Shandiz, Mehdi, Aarabi, Mohammad Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224341/
https://www.ncbi.nlm.nih.gov/pubmed/30450079
http://dx.doi.org/10.3389/fendo.2018.00608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224341/
https://www.ncbi.nlm.nih.gov/pubmed/30450079
http://dx.doi.org/10.3389/fendo.2018.00608

Ejemplares similares